Refine by
Oncology Care Articles & Analysis
22 news found
Commercial and Pipeline Update Product portfolio Acute Care Hospital: RYANODEX®, vasopressin, Barhemsys®, Byfavo® Oncology: BENDEKA, BELRAPZO, PEMFEXY11, TREAKISYM Japan12 75-person commercial team covers all products excluding BENDEKA and TREAKISYM Company projects growth in earnings while still supporting R&D Cash flow from legacy ...
Since its initial launch in February 2022, PEMFEXY has been an important addition to Eagle’s hospital and acute care product portfolio, and we are pleased to bring this treatment option to patients undergoing chemotherapy. ...
About ESMO Founded in 1975, ESMO has European roots with a global reach. Home for all oncology stakeholders, ESMO connects professionals with diverse expertise and experience. Its education and information resources support an integrated multi-professional approach to cancer care, from a medical oncology perspective. ESMO is the leading ...
ENA-001 would be used potentially as monotherapy or in conjunction with current standard of care, caffeine. Represents strong strategic fit with Eagle’s specialized sales and marketing organization and current and expanding portfolio of hospital and anesthesia products. ...
This complementary alliance will support iSTAR Medical’s development and commercial efforts for MINIject®, as well as provide an opportunity to expand AbbVie’s eye care business, building on its glaucoma portfolio which includes drops, sustained release implants, and stent offerings. ...
It has the potential to revolutionize radiation oncology, having demonstrated compelling success in some of the most difficult-to-treat cancers and in treating patients for whom all other treatment options have been exhausted. ...
It has the potential to revolutionize radiation oncology, having demonstrated compelling success in some of the most difficult-to-treat cancers and in treating patients for whom all other treatment options have been exhausted. ...
Now through the end of 2022, PatientPoint will promote Komen content on PatientPoint’s Interact Exam Room Platform and Provider Access Platform in primary care, OB/GYN and oncology practices in Atlanta, Chicago, Dallas, Houston, Indianapolis, Los Angeles, Memphis, Philadelphia, St. ...
This would allow doctors to detect recurrences sooner than current standard of care and to thus start aggressive treatments sooner with potentially better ...
Abstracts will be published online following the conference in the journal Oncology. “The Miami Breast Cancer Conference is run by leaders in breast cancer care from every oncology specialty,” commented Richard Carreon, Managing Director and CEO of ImpediMed. ...
Southern Oncology Specialists offers comprehensive cancer care and serves patients in four locations in the greater Charlotte region. ...
Ocala Oncology/Florida Cancer Affiliates specializes in hematology and oncology care and serves patients in the Central Florida area. ...
“Our latest strategic collaboration with GeneCentric will draw upon their industry-leading RNA-based signatures and help facilitate the creation of better tools for oncology diagnostics, drug development and patient care,” said Steven Anderson, Ph.D., senior vice president and chief scientific officer at Labcorp Drug Development. ...
He has advocated establishing clinical guidelines for TDM and pharmacology in oncology for over 15 years. Dr. Salamone accepted this award as a great honor and paid tribute to the influence Dr. ...
“The ODS Medical team is very excited to welcome new investors to our efforts to provide more data-driven surgical oncology care to cancer patients,” said Christopher Kent, President & CEO of ODS Medical. ...
“The support provided by these world-class investors is an important milestone for our journey to transform cancer care and dramatically improve patient survival by enabling personalized precision oncology and bringing transformative medicines to patients faster and with higher success rates,” added Dr. ...
He currently acts as owner of Teich & Teich Health Care, a company that supports health management. “My extensive career in oncology has exposed me to the true impact that technology can have on the fight against cancer, which is why the revolutionary nature of 4D Path’s technology truly caught my attention,” said Dr. ...
Researchers concluded that PixCell's HemoScreen™, a miniature, easy-to-use, AI and machine vision-enabled hematology analyzer, can fill the gap in point-of-care (POC) diagnostics. The paper, titled A Novel Approach to Hematology Testing at the Point-Of-Care, compares the traditional analysis methods used for blood cell counting to the new imaging flow ...
Cancer Therapy Advisor (CTA), a leading source of cancer research news and drug information, has been named one of the top breast cancer apps of 2020 by Healthline for the fifth year in a row. The CTA app is designed for oncology professionals and compiles oncology research news, practical cancer treatment regimens, feature articles and expert interviews, ...
Galleri is among the most promising new tools in the fight against cancer, and we are thrilled to welcome GRAIL back to Illumina to help transform cancer care using genomics and our NGS platform,” said Francis deSouza, Illumina’s President and Chief Executive Officer. ...